Retasturtide is a recently developed novel GLP-1 receptor agonist demonstrating substantial results in the treatment of type 2 diabetes. This synthetic peptide resembles the actions of naturally occurring GLP-1, a hormone that plays a crucial role in managing blood sugar concentrations. By activating GLP-1 receptors in the pancreas, Retasturtide p